CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas-Reference-Cited by-同舟云学术

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Published:2020-07-08 Issue:3 Volume:140 Page:409-413
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Sievers Philipp,Hielscher Thomas,Schrimpf Daniel,Stichel Damian,Reuss David E.,Berghoff Anna S.,Neidert Marian C.,Wirsching Hans-Georg,Mawrin Christian,Ketter Ralf,Paulus Werner,Reifenberger Guido,Lamszus Katrin,Westphal Manfred,Etminan Nima,Ratliff Miriam,Herold-Mende Christel,Pfister Stefan M.,Jones David T. W.,Weller Michael,Harter Patrick N.,Wick Wolfgang,Preusser Matthias,von Deimling Andreas,Sahm Felix^ORCID

Funder

Else Kröner-Fresenius-Stiftung

Deutsche Krebshilfe

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00401-020-02188-w.pdf

Reference13 articles.

1. Bostrom J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661–669. https://doi.org/10.1016/S0002-9440(10)61737-3

2. Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000